Anya Menzies, MD
Gynecologic Oncology · Fort Wayne, INNPI 1033537345
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for gynecologic oncology clinicians in IN, where the typical reported total is $1,688.
Across 16 payments — averaging $61.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$149
- Olympus America Inc.$139
- Myriad Genetic Laboratories, Inc.$138
- Astellas Pharma US Inc$125
- GSK$125
- Genmab U.S., Inc.$115
- plus $197 from 4 others
Across 5 payments — averaging $11,798 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$59K
What the payments were for
- Food & beverage$988100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $149 |
| Olympus America Inc. | 1 | $139 |
| Myriad Genetic Laboratories, Inc. | 2 | $138 |
| Astellas Pharma US Inc | 1 | $125 |
| GSK | 1 | $125 |
| Genmab U.S., Inc. | 1 | $115 |
| Eisai Inc. | 1 | $72 |
| Merck | 6 | $69 |
| Myriad Women's Health, Inc. | 1 | $32 |
| Caris MPI, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Actishield$149
- ALLOWRAP$149
- ACTISHIELD CF$149
- ThunderBeat$139
- Veozah$125
- JEMPERLI$125
- myRisk$118
- TIVDAK$115
How this compares
$988 in reported general payments places this provider in the 25th percentile of 26 gynecologic oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $10,914 |
| Ondansetron OdtOndansetron | 15 | $318 |
| Dexamethasone | 16 | $297 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $171 |
| Prochlorperazine Maleate | 17 | $161 |
| Oxycodone Hcl | 27 | $67 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Fort Wayne
- Scott GoodrichFort Wayne$4K
- Bogna BrzezinskaFort Wayne$3K
- John GeislerFort Wayne$547
- Sameer SharmaDyer$27K
- Nonyem OnujioguSouth Bend$23K
- Paul LiuSouth Bend$15K
- Iwona PodzielinskiWarsaw$8K
- Jessica Parker MetterIndianapolis$6K
- Hilary HinshawIndianapolis$5K
- Lisa LandrumIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.